C.I. MedicalLtd Valuation

Is 3540 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 3540 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3540 (¥1023) is trading above our estimate of fair value (¥169.01)

Significantly Below Fair Value: 3540 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3540?

Key metric: As 3540 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 3540. This is calculated by dividing 3540's market cap by their current earnings.
What is 3540's PE Ratio?
PE Ratio9x
EarningsJP¥5.68b
Market CapJP¥51.15b

Price to Earnings Ratio vs Peers

How does 3540's PE Ratio compare to its peers?

The above table shows the PE ratio for 3540 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average14.3x
3151 Vital KSK Holdings
9.7xn/aJP¥57.3b
9729 TOKAI
12.1x3.7%JP¥75.1b
3183 WIN-Partners
17.7xn/aJP¥35.0b
2393 Nippon Care Supply
17.8xn/aJP¥29.7b
3540 C.I. MedicalLtd
9x-10.1%JP¥51.1b

Price-To-Earnings vs Peers: 3540 is good value based on its Price-To-Earnings Ratio (9x) compared to the peer average (14.3x).


Price to Earnings Ratio vs Industry

How does 3540's PE Ratio compare vs other companies in the JP Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
3540 9.0xIndustry Avg. 14.2xNo. of Companies9PE0816243240+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 3540 is good value based on its Price-To-Earnings Ratio (9x) compared to the JP Healthcare industry average (13.8x).


Price to Earnings Ratio vs Fair Ratio

What is 3540's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3540 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio9x
Fair PE Ratio13.2x

Price-To-Earnings vs Fair Ratio: 3540 is good value based on its Price-To-Earnings Ratio (9x) compared to the estimated Fair Price-To-Earnings Ratio (13.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies